ATE253223T1 - Verfahren und materialien zur diagnose instabiler angina - Google Patents

Verfahren und materialien zur diagnose instabiler angina

Info

Publication number
ATE253223T1
ATE253223T1 AT99943950T AT99943950T ATE253223T1 AT E253223 T1 ATE253223 T1 AT E253223T1 AT 99943950 T AT99943950 T AT 99943950T AT 99943950 T AT99943950 T AT 99943950T AT E253223 T1 ATE253223 T1 AT E253223T1
Authority
AT
Austria
Prior art keywords
materials
methods
unstable angina
stable
unstable
Prior art date
Application number
AT99943950T
Other languages
English (en)
Inventor
Jorg G Goronzy
Cornelia M Weyand
Giovanna Liuzzo
Original Assignee
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation filed Critical Mayo Foundation
Application granted granted Critical
Publication of ATE253223T1 publication Critical patent/ATE253223T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/324Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99943950T 1998-08-27 1999-08-27 Verfahren und materialien zur diagnose instabiler angina ATE253223T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9812098P 1998-08-27 1998-08-27
PCT/US1999/019536 WO2000013021A1 (en) 1998-08-27 1999-08-27 Methods and materials for diagnosing unstable angina

Publications (1)

Publication Number Publication Date
ATE253223T1 true ATE253223T1 (de) 2003-11-15

Family

ID=22267292

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99943950T ATE253223T1 (de) 1998-08-27 1999-08-27 Verfahren und materialien zur diagnose instabiler angina

Country Status (9)

Country Link
US (2) US6635433B1 (de)
EP (1) EP1108212B1 (de)
JP (1) JP2002523782A (de)
AT (1) ATE253223T1 (de)
AU (1) AU756694B2 (de)
CA (1) CA2341619A1 (de)
DE (1) DE69912453T2 (de)
ES (1) ES2212615T3 (de)
WO (1) WO2000013021A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1668922A (zh) * 2002-06-26 2005-09-14 拉尔夫·赫维希 用于循环性巨噬细胞的性质确定和/或分类的方法以及施行该方法的分析安排
GB0412859D0 (en) * 2004-06-09 2004-07-14 Immunoclin Ltd Markers for atherosclerosis
EP2321646A1 (de) * 2008-08-04 2011-05-18 Synmed Research GmbH Verfahren zur charakterisierung, insbesondere quantifizierung, von durch, aus dem gewebe in die blutbahn rezirkulierten, blutmakrophagen intrazellulär aus gewebe aufgenommenen molekularen markern sowie analyseanordnung zur durchführung des verfahrens
EP2607899B1 (de) * 2011-12-21 2016-08-10 Beckman Coulter, Inc. Verfahren zur Markierung intrazellulärer und extrazellulärer Zielstrukturen von Leukozyten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424187A (en) * 1991-06-14 1995-06-13 Board Of Regents Of The University Of Washington Method of screening for arterial chlamydial granuloma
US5834248A (en) * 1995-02-10 1998-11-10 Millennium Pharmaceuticals Inc. Compositions and methods using rchd534, a gene uregulated by shear stress
DK1493439T3 (da) * 1997-04-02 2012-01-30 Brigham & Womens Hospital Middel til fastlæggelse af en persons risikoprofil for aterosklerotisk sygdom

Also Published As

Publication number Publication date
US6635433B1 (en) 2003-10-21
EP1108212A4 (de) 2001-09-19
DE69912453T2 (de) 2004-07-22
WO2000013021A1 (en) 2000-03-09
AU5694099A (en) 2000-03-21
AU756694B2 (en) 2003-01-23
US20050260690A1 (en) 2005-11-24
JP2002523782A (ja) 2002-07-30
EP1108212B1 (de) 2003-10-29
ES2212615T3 (es) 2004-07-16
EP1108212A1 (de) 2001-06-20
DE69912453D1 (de) 2003-12-04
US7244579B2 (en) 2007-07-17
CA2341619A1 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
EP1099102A4 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
EP1687283A4 (de) Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
AU1929199A (en) Methods for the recovery and measurement of troponin complexes
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
ATE278805T1 (de) Verfahren zur quantifizierung von cholesterol in lipoproteinen und quantifizierungsreagenzien
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
EP2293075A3 (de) Verfahren zur Diagnose neurodegenerativer Erkrankungen
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
WO2002067760A3 (en) Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
DE60228557D1 (de) Candida-nachweis
DE69836493D1 (de) Vorrichtung zur bestimmung von mehreren analyten
ES2079481T3 (es) Un procedimiento para la determinacion de la actividad funcional de la proteina s o de la proteina c libre en una muestra de plasma.
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
SE9604815D0 (sv) A metod of diagnosis
AU2003259222A1 (en) Method of diagnosing alzheimer's disease
AU7571998A (en) Rapid evaluation of the ratio of biological molecules
BR0014626A (pt) Análise de leptina
ATE253223T1 (de) Verfahren und materialien zur diagnose instabiler angina
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
EP0899541A3 (de) Apparat zur Bestimmung der Dicke eines optischen Prüfkörpers
FR2795823B1 (fr) Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial
MXPA04003084A (es) Portador de muestras con pinzas.
AU2001258614A1 (en) Diagnostic method for alzheimer's disease based on holo-transcobalamin ii
AU8904598A (en) Methods, kits, electrodes and compositions for assessing the level of an analyteof interest in fluid samples

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1108212

Country of ref document: EP

REN Ceased due to non-payment of the annual fee